Big Pharma will not grant bail to battered biotech

Share Market It may have been in a recession, but the Biotechnology Index has fallen off…

Bristol-Myers to buy Turning Point Therapeutics for $4.1 billion

Bristol-Myers Squibb Company said it has agreed to buy clinical-stage precision-oncology company Turning Point Therapeutics Deepening…